1218.5.10001 Boehringer Ingelheim Investigational Site — La Jolla, California

1218.5.10001 Boehringer Ingelheim Investigational Site is a clinical research site located in La Jolla, California, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

1218.5.10001 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in La Jolla

Browse all research sites in California · View every site in La Jolla

• University of California, San Diego Mores Cancer Center
• University of California San Diego OTIS
• University of California, Moores Cancer Center
• University of California, San Diego, School of Medicine, Division of Global Public Health
• Scripps Green Hospital/Scripps Clinic
• Ocugen Site 5 - University of California, San Diego (UCSD) - Shiley Eye Institute
• Department of Interventional Psychiatry, University of California San Diego
• Shiley Eye Center, Hamilton Glaucoma Center, University of California, San Diego
• University of California San Diego Center for Innovative Therapy
• Site 1013 University of California, San Diego - Altman Clinical and Translational Research Institute
• Green Hospital of Scripps Health
• Shiley Eye Center Center, 0946, University of California, San Diego

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 1218.5.10001 Boehringer Ingelheim Investigational Site?

1218.5.10001 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 1218.5.10001 Boehringer Ingelheim Investigational Site conducted?

1218.5.10001 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is 1218.5.10001 Boehringer Ingelheim Investigational Site accredited by Crixeo Clinical Trials?

1218.5.10001 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 1218.5.10001 Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.